{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:00:44Z","timestamp":1784095244027,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2662020DKPY020"],"award-info":[{"award-number":["2662020DKPY020"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["PID 2020-115979RR-C33"],"award-info":[{"award-number":["PID 2020-115979RR-C33"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFD0501401"],"award-info":[{"award-number":["2017YFD0501401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32473087"],"award-info":[{"award-number":["32473087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["Project\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["Project\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["13039\/501100011033"],"award-info":[{"award-number":["13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["\/AEI\/10"],"award-info":[{"award-number":["\/AEI\/10"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117420","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:50:53Z","timestamp":1760223053000},"page":"117420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P4","title":["Zaltoprofen and its novel analogues exhibit dual targeting of COX-2 and PPAR-\u03b3, providing a strategy to alleviate lipopolysaccharide \u2013 induced acute lung injury"],"prefix":"10.1016","volume":"242","author":[{"given":"Qirong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Lopez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Rosa","family":"Mart\u00ednez-Larra\u00f1aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Anad\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Ar\u00e1nzazu","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117420_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4155\/fmc.12.193","article-title":"Challenges in the design of multitarget drugs against multifactorial pathologies: a new life for medicinal chemistry?","volume":"5","author":"Costantino","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2025.117420_b0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117420_b0015","first-page":"1361","article-title":"Multiple target-centric strategy to tame inflammation, Future","volume":"9","author":"Kaur","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.bcp.2025.117420_b0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117420_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000550","article-title":"Structure of protein interaction networks and their implications on drug design","volume":"5","author":"Hase","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bcp.2025.117420_b0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117420_b0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.329.7470.816-a","article-title":"Merck withdraws arthritis drug worldwide","volume":"329","author":"Singh","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.bcp.2025.117420_b0040","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1093\/rheumatology\/keh105","article-title":"Licofelone-clinical update on a novel LOX\/COX inhibitor for the treatment of osteoarthritis","volume":"43","author":"Alvaro-Gracia","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.bcp.2025.117420_b0045","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.7150\/thno.43108","article-title":"A COX-2\/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2025.117420_b0050","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/nu12061742","article-title":"Attenuation of lipopolysaccharide-induced acute lung injury by hispolon in mice, through regulating the TLR4\/PI3K\/Akt\/mTOR and Keap1\/Nrf2\/HO-1 pathways, and suppressing oxidative stress-mediated ER stress-induced apoptosis and autophagy","volume":"12","author":"Huang","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2025.117420_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bcp.2025.117420_b0060","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1080\/15548627.2016.1230584","article-title":"Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury","volume":"12","author":"Hu","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2025.117420_b0065","first-page":"131","article-title":"Effect of a novel anti-inflammatory drug, 2-(10, 11-dihydro-10-oxo-dibenzo[b,f]-thiepin-2-yl)propionic acid (CN-100), on the proteoglycan biosynthesis in articular chondrocytes and prostaglandin E2 production in synovial fibroblasts","volume":"70","author":"Ito","year":"1990","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117420_b0070","first-page":"2167","article-title":"Pharmacokinetics of CN-100 for 80 mg tablet of final preparation in healthy volunteers","volume":"20","author":"Sasaki","year":"1992","journal-title":"Jpn. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117420_b0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neures.2005.12.016","article-title":"Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors","volume":"54","author":"Hirate","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bcp.2025.117420_b0080","first-page":"369","article-title":"NSAID zaltoprofen improves the decrease in body weight in rodent sickness behavior models: proposed new applications of NSAIDs (Review)","volume":"9","author":"Okamoto","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2025.117420_b0085","first-page":"1801","article-title":"Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions","volume":"36","author":"Tsurumi","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bcp.2025.117420_b0090","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117420_b0095","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1056\/NEJMoa052052","article-title":"Lung recruitment in patients with the acute respiratory distress syndrome","volume":"354","author":"Gattinoni","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117420_b0100","first-page":"256","article-title":"Neurotropic and psychotropic agents: 9-chloro-10-(4-methylpiperazino)-10,11-dihydrodibenzo(b,f)thiepin. (preliminary communication)","volume":"28","author":"Sindel\u00e1r","year":"1973","journal-title":"Farmaco Sci."},{"key":"10.1016\/j.bcp.2025.117420_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202114482","article-title":"Controlling chemoselectivity of catalytic hydroboration with light","volume":"61","author":"Bergamaschi","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bcp.2025.117420_b0110","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/jhet.5570230513","article-title":"The synthesis of 3-hydroxymethyldibenzo[b,f]thiepin 5,5-dioxide, a prostaglandin antagonist","volume":"23","author":"Hands","year":"1986","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bcp.2025.117420_b0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0031-1290079","article-title":"Synthetic protocols mutually applicable to 4-oxoquinolines and 4-oxo-1,8-naphthyridines: synthesis of 1-aryl-2-substituted and 1-aryl-3-fluoro-4-oxoquinolines and 4-oxo-1,8-naphthyridines","volume":"23","author":"Awasaguchi","year":"2012","journal-title":"Synlett"},{"key":"10.1016\/j.bcp.2025.117420_b0120","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1039\/C9SC04177J","article-title":"Nickel-catalyzed hydroalkylation and hydroalkenylation of 1,3-dienes with hydrazones","volume":"10","author":"Cheng","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bcp.2025.117420_b0125","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1246\/bcsj.65.1636","article-title":"Diphenyl (2,3-dihydro-2-thioxo-3-benzoxazolyl)phosphonate: a new, reactive condensing agent for the synthesis of amides, esters, peptides, and \u03b2-lactams via condensation","volume":"65","author":"Ueda","year":"1992","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.bcp.2025.117420_b0130","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1016\/j.tetlet.2007.03.173","article-title":"Preparation and condensation reactions of a new light-fluorous Mukaiyama reagent: reliable purification with fluorous solid phase extraction for esters and amides","volume":"48","author":"Matsugi","year":"2007","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bcp.2025.117420_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111270","article-title":"Diosgenin alters LPS-induced macrophage polarization by activating PPAR\u03b3\/NF-\u03baB signaling pathway","volume":"126","author":"Xiang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117420_b0140","doi-asserted-by":"crossref","first-page":"e2597","DOI":"10.1038\/cddis.2017.24","article-title":"MicroRNA-144 is regulated by CP2 and decreases COX-2 expression and PGE2 production in mouse ovarian granulosa cells","volume":"8","author":"Zhou","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117420_b0145","doi-asserted-by":"crossref","first-page":"29512","DOI":"10.1021\/acsomega.3c03256","article-title":"New thiazole carboxamide derivatives as COX inhibitors: design, synthesis, anticancer screening, in silico molecular docking, and ADME profile studies","volume":"8","author":"Hawash","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bcp.2025.117420_b0150","unstructured":"LLC. Schr\u00f6dinger, The PyMOL molecular graphics system, version 1.8, Schr\u00f6dinger, LLC; New York, USA (2015)."},{"key":"10.1016\/j.bcp.2025.117420_b0155","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117420_b0160","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","volume":"76","author":"Adzhubei","year":"2013","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.bcp.2025.117420_b0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13036-019-0157-4","article-title":"Analysis of the stability and affinity of BlaR-CTD protein to \u03b2-lactam antibiotics based on docking and mutagenesis studies","volume":"13","author":"Ning","year":"2019","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.bcp.2025.117420_b0170","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0009-9236(99)70113-X","article-title":"Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model","volume":"65","author":"Ehrich","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117420_b0175","series-title":"Chemical Biology. Methods and Protocols","first-page":"287","article-title":"Drug affinity responsive target stability (DARTS) for small-molecule target identification","author":"Pai","year":"2015"},{"key":"10.1016\/j.bcp.2025.117420_b0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1254\/jjp.72.29","article-title":"Antinociceptive activity of a novel non-steroidal anti-inflammatory drug (M-5011) with low ulcerogenic effects in mice","volume":"72","author":"Murakami","year":"1996","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117420_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112615","article-title":"Self-developed NF-\u03baB inhibitor 270 protects against LPS-induced acute kidney injury and lung injury through improving inflammation","volume":"147","author":"Yu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117420_b0190","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13915","article-title":"Protocatechuic acid attenuates lipopolysaccharide-induced septic lung injury in mice: the possible role through suppressing oxidative stress, inflammation and apoptosis","volume":"45","author":"Alsharif","year":"2021","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.bcp.2025.117420_b0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2011.01.019","article-title":"Molecular cross-regulation between PPAR-\u03b3 and other signaling pathways: implications for lung cancer therapy","volume":"72","author":"Reka","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2025.117420_b0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.intimp.2016.09.028","article-title":"PPAR-\u03b3 agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-\u03baB pathways","volume":"41","author":"Zhu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117420_b0205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imm.12305","article-title":"Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway","volume":"143","author":"Yao","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2025.117420_b0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2008.03.057","article-title":"Evaluation of COX-1\/COX-2 selectivity and potency of a new class of COX-2 inhibitors","volume":"588","author":"Gierse","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117420_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115138","article-title":"Development of novel pyrazole, imidazo[1,2-b]pyrazole, and pyrazolo[1,5-a]pyrimidine derivatives as a new class of COX-2 inhibitors with immunomodulatory potential","volume":"249","author":"Ayman","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117420_b0220","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1021\/jm0302391","article-title":"Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors","volume":"46","author":"Praveen Rao","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117420_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117499","article-title":"Unveiling a novel pyrazolopyrimidine scaffold as a dual COX-2\/5-LOX inhibitor with immunomodulatory potential: design, synthesis, target prediction, anti-inflammatory activity, and ADME-T with docking simulation","volume":"290","author":"Ragab","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117420_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108097","article-title":"Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting \u03b1-glucosidase, \u03b1-amylase, and PPAR-\u03b3: design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus","volume":"111","author":"Thabet","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117420_b0235","doi-asserted-by":"crossref","first-page":"15691","DOI":"10.1039\/D4RA02143F","article-title":"Innovation of 6-sulfonamide-2H-chromene derivatives as antidiabetic agents targeting \u03b1-amylase, \u03b1-glycosidase, and PPAR-\u03b3 inhibitors with in silico molecular docking simulation","volume":"14","author":"Thabet","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bcp.2025.117420_b0240","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2019.05.008","article-title":"Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling","volume":"457","author":"Lin","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2025.117420_b0245","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117420_b0250","doi-asserted-by":"crossref","first-page":"e004","DOI":"10.1621\/nrs.13004","article-title":"Mechanisms of peroxisome proliferator activated receptor \u03b3 regulation by non-steroidal anti-inflammatory drugs","volume":"13","author":"Puhl","year":"2015","journal-title":"Nucl. Recep. Signal."},{"key":"10.1016\/j.bcp.2025.117420_b0255","first-page":"S353","article-title":"Acute lung injury-from pathophysiology to treatment","volume":"69","author":"Mokr\u00e1","year":"2020","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bcp.2025.117420_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156432","article-title":"Norwogonin attenuates LPS-induced acute lung injury through inhibiting Src\/AKT1\/NF-\u03baB signaling pathway","volume":"139","author":"Cao","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2025.117420_b0265","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s10787-025-01693-2","article-title":"Kirenol ameliorates endotoxin-induced acute lung injury by inhibiting the ERK and JNK phosphorylation-mediated NF\u03baB pathway in mice","volume":"33","author":"Lin","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bcp.2025.117420_b0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13258-023-01455-w","article-title":"ACT001 alleviates inflammation and pyroptosis through the PPAR-\u03b3\/NF-\u03baB signaling pathway in LPS-induced alveolar macrophages","volume":"46","author":"Fu","year":"2024","journal-title":"Genes Genom."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:49:22Z","timestamp":1778636962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"alternative-id":["S0006295225006859"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117420","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zaltoprofen and its novel analogues exhibit dual targeting of COX-2 and PPAR-\u03b3, providing a strategy to alleviate lipopolysaccharide \u2013 induced acute lung injury","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117420"}}